Anywhere-anytime signals and systems laboratory : from MATLAB to smartphones / / Nasser Kehtarnavaz and Fatemeh Saki |
Autore | Kehtarnavaz Nasser |
Pubbl/distr/stampa | [San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 |
Descrizione fisica | 1 online resource (212 pages) : illustrations (some color) |
Disciplina | 621.3822 |
Collana | Synthesis Lectures on Signal Processing |
Soggetto topico |
Signal processing - Digital techniques
Smartphones Real-time data processing |
ISBN | 1-62705-503-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Preface -- 1. Introduction to MATLAB: 1.1. Starting MATLAB; 1.2. MATLAB programming examples; 1.3. Lab exercises -- 2. Android software development tools: 2.1. Installation steps; 2.2. Getting familiar with Android software tools -- 3. From MATLAB Coder to smartphone: 3.1. MATLAB function design; 3.2. Generating signals via MATLAB on smartphones; 3.3. Running MATLAB Coder C codes on smartphones; 3.4. References -- 4. Linear time-invariant systems and convolution: 4.1. Convolution and its numerical approximation; 4.2. Convolution properties; 4.3. Convolution experiments; 4.4. Lab exercises; 4.5. Running MATLAB Coder C codes on smartphone; 4.6. Running in real-time on smartphones; 4.7. References -- 5. Fourier series: 5.1. Fourier series numerical computation; 5.2. Fourier series and its applications; 5.3. Lab exercises; 5.4. References -- 6. Continuous-time Fourier transform: 6.1. CTFT and its properties; 6.2. Numerical approximations of CTFT; 6.3. Evaluating properties of CTFT; 6.4. Lab exercises; 6.5. References -- 7. Digital signals and their transforms: 7.1. Digital signals; 7.2. Analog-to-digital conversion, DTFT, and DFT; 7.3. Lab exercises; 7.4. References -- Authors' biographies -- Index. |
Record Nr. | UNINA-9910149015703321 |
Kehtarnavaz Nasser
![]() |
||
[San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The biliary system / / David Q.-H. Wang, Brent A. Neuschwander-Tetri, Piero Portincasa |
Autore | Wang David Q.-H. |
Edizione | [Second edition.] |
Pubbl/distr/stampa | [San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 |
Descrizione fisica | 1 online resource (192 pages) |
Disciplina | 616.36 |
Collana | Colloquium Series on Integrated Systems Physiology : From Molecule to Function |
Soggetto topico | Biliary tract - Diseases |
ISBN | 1-61504-738-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
1. Introduction --
2. Anatomy of the liver, biliary tract, and gallbladder -- 2.1 The liver -- 2.1.1 Gross and surface anatomy -- 2.1.2 Structural concepts of liver lobes and segmentation -- 2.1.3 Large vessels of the liver -- 2.1.3.1 Portal veins -- 2.1.3.2 Hepatic arteries -- 2.1.3.3 Hepatic veins -- 2.1.4 Lymphatic drainage -- 2.2 The biliary tract and gallbladder -- 2.2.1 Intrahepatic bile ducts -- 2.2.2 Extrahepatic bile ducts -- 2.2.3 Gallbladder -- 2.3 Liver, gallbladder, and bile duct cell types -- 2.3.1 Parenchymal cells -- 2.3.1.1 Hepatocytes -- 2.3.2 Sinusoidal nonparenchymal cells -- 2.3.2.1 Hepatic sinusoidal endothelial cells -- 2.3.2.2 Kupffer cells -- 2.3.3 Perisinusoidal nonparenchymal cells -- 2.3.3.1 Hepatic stellate cells -- 2.3.3.2 Pit cells -- 2.3.4 Gallbladder cells -- 2.3.5 Bile duct epithelial cells -- 3. Physical chemistry of bile -- 3.1 Chemical composition of bile -- 3.2 Biliary cholesterol -- 3.3 Biliary bile acids -- 3.4 Biliary phospholipids -- 3.5 Bile pigments -- 4. Hepatic cholesterol metabolism -- 4.1 Physical chemistry of cholesterol -- 4.2 Features of cholesterol balance in the body -- 4.3 Cholesterol synthesis rates -- 4.4 Cholesterol biosynthesis pathways -- 4.4.1 The conversion of three acetyl CoA molecules to mevalonate -- 4.4.2 Synthesis of two activated isoprenes from mevalonate -- 4.4.3 Synthesis of the 30-carbon squalene from six activated isoprenes -- 4.4.4 Cholesterol is synthesized from squalene via lanosterol -- 4.5 Regulation of hepatic cholesterol biosynthesis -- 5. Physical chemistry and hepatic metabolism of bile acids -- 5.1 Chemical structure and physical-chemical properties of bile acids -- 5.2 Hydrophilic-hydrophobic balance of bile acids -- 5.3 Bile acid biosynthesis pathways -- 5.4 Regulation of bile acid biosynthesis -- 5.5 Inhibitory mechanisms of FXR signaling on CYP7A1 -- 5.5.1 The FXR/SHP pathway -- 5.5.2 The FXR/FGF19/FGFR4 pathway -- 5.6 FXR-independent bile acid inhibition of CYP7A1 -- 6. The enterohepatic circulation of bile acids -- 6.1 Physiology of the enterohepatic circulation -- 6.2 Bile acid pool and kinetics -- 6.3 Driving forces of the enterohepatic circulation -- 6.4 Kinetics and regulation of the enterohepatic circulation -- 6.4.1 The hepatic uptake of bile acids -- 6.4.1.1 Hepatic sinusoidal sodium-dependent bile acid uptake -- 6.4.1.2 Hepatic sinusoidal sodium-independent bile acid uptake -- 6.4.2 The canalicular transport of bile acids -- 6.4.3 The role of gallbladder in the enterohepatic circulation -- 6.4.4 The role of the intestine in the maintenance of the enterohepatic circulation -- 6.4.4.1 Ileal sodium-dependent bile acid uptake -- 6.4.5 The role of kidneys in the enterohepatic circulation -- 6.4.5.1 Renal sodium-dependent bile acid uptake -- 7. Hepatic secretion of biliary lipids and bile formation -- 7.1 Structure of the bile secretory apparatus -- 7.2 Source of lipids secreted in bile -- 7.3 Biliary lipid secretion -- 7.4 Canalicular bile flow -- 7.4.1 Bile acid-dependent bile flow -- 7.4.2 Bile acid-independent bile flow -- 7.5 Physical states of biliary lipids -- 7.6 Biliary micelles -- 7.7 Biliary vesicles, nonmicellar carriers of cholesterol in bile -- 7.8 Co-existence and interconversion of micelles and vesicles in bile -- 8. Cholesterol crystallization and gallstone formation -- 8.1 Introduction -- 8.2 Five primary defects in the pathogenesis of cholesterol gallstone disease -- 8.3 Pathophysiology of cholesterol gallstone formation -- 8.3.1 Phase diagrams and cholesterol solubility in bile -- 8.3.2 Cholesterol nucleation and crystallization in supersaturated bile -- 8.3.3 Cholesterol crystal detection time -- 8.3.4 Agents influencing cholesterol nucleation and crystallization -- 8.3.5 Pro-nucleating agents -- 8.3.6 Anti-nucleating agents -- 8.3.7 Solid cholesterol crystal growth -- 8.4 Future directions -- 9. Summary -- Acknowledgments -- References -- Author biographies. |
Record Nr. | UNINA-9910156411403321 |
Wang David Q.-H.
![]() |
||
[San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The blood-brain barrier in health and disease / / William G. Mayhan, Denise M. Arrick |
Autore | Mayhan William G. |
Pubbl/distr/stampa | [San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 |
Descrizione fisica | 1 online resource (77 pages) : illustrations (some color) |
Disciplina | 612.824 |
Collana | Colloquium Series on Integrated Systems Physiology: From Molecule to Function |
Soggetto topico |
Blood-brain barrier
Blood-brain barrier disorders |
Soggetto genere / forma | Electronic books. |
ISBN | 1-61504-740-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
1. Introduction --
2. Characteristics of the blood-brain barrier -- 2.1 Development of the blood-brain barrier -- 2.2 Endothelial transport systems -- 3. Ultrastructural components of the blood-brain barrier -- 3.1 Tight junctional proteins -- 3.1.1 Occludin -- 3.1.2 Claudin -- 3.1.3 Junctional adhesion molecule -- 3.1.4 Accessory proteins -- 3.2 Adherens junctions -- 4. Cellular components of the blood-brain barrier -- 4.1 Astrocytes -- 4.2 Pericytes -- 4.3 Neurons -- 4.4 Microglia -- 5. Compromising the blood-brain barrier -- 5.1 Site of disruption of the blood-brain-barrier -- 5.2 Seizures/acute hypertension -- 5.3 Neuroinflammatory diseases -- 5.4 Diabetes -- 5.5 Traumatic brain injury -- 5.6 Cerebral ischemia/stroke -- 6. Summary -- References -- About the authors. |
Record Nr. | UNINA-9910156411503321 |
Mayhan William G.
![]() |
||
[San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cardiovascular responses to exercise / / Lusha Xiang and Robert L. Hester |
Autore | Xiang Lusha |
Edizione | [Second edition.] |
Pubbl/distr/stampa | [San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 |
Descrizione fisica | 1 online resource (135 pages) : color illustrations |
Disciplina | 612.1 |
Collana | Colloquium Series on Integrated Systems Physiology : From Molecule to Function Disease |
Soggetto topico |
Cardiovascular system
Exercise - Physiological aspects |
ISBN | 1-61504-727-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
1. Capillary perfusion in skeletal muscle during exercise -- 1.1 Capillary perfusion at rest -- 1.1.1 Capillary vasomotion -- 1.1.2 Microcirculatory units -- 1.2 Regulation of capillary perfusion during exercise -- 1.2.1 Capillary perfusion during exercise -- 1.2.2 Factors determining capillary perfusion -- 1.3 Oxygen delivery to skeletal muscle during exercise -- 1.3.1 Oxygen gradient -- 1.3.2 Bohr effect -- 1.3.3 Oxygen deficient at onset of exercise --
2. Local control of arteriolar diameter and blood flow during exercise -- 2.1 Increased blood flow during exercise (functional hyperemia) -- 2.2 Blood flow control at the onset of exercise (phase I) -- 2.2.1 Oxygen delivery at the onset of exercise -- 2.2.2 Functional vasodilation and blood flow control at the onset of exercise -- 2.2.2.1 Muscle pump -- 2.2.2.2 Neurogenic vasodilation in skeletal muscle -- 2.2.3 Metabolic control (potassium) -- 2.2.4 Flow-mediated vasodilation -- 2.3 Blood flow control during steady-state dynamic exercise (phase II) -- 2.3.1 Metabolite control -- 2.3.1.1 Potassium -- 2.3.1.2 Oxygen -- 2.3.1.3 Hydrogen ion -- 2.3.1.4 Lactate -- 2.3.1.5 Adenosine -- 2.3.1.6 ATP -- 2.3.2 Endothelium-dependent vasoactive metabolites -- 2.3.2.1 Nitric oxide -- 2.3.2.2 Prostanoids -- 2.3.2.3 Endothelium-derived hyperpolarizing factors -- 2.3.3 Venular-arteriolar diffusion -- 2.3.3.1 Anatomy and "communication" of paired vessels -- 2.3.3.2 Regulation of arteriolar tone by paired venular endothelium-derived factors during exercise -- 2.3.3.3 Regulation of arteriolar tone by paired venular blood PO2 during exercise -- 2.3.3.4 Low venular PO2 and resultant increased ATP-induced production of prostanoids -- 2.3.4 Flow-mediated and conducted vasodilation -- 2.3.4.1 Flow-mediated vasodilation -- 2.3.4.2 Conducted vasodilation -- 2.3.5 Neural control of functional vasodilation -- 2.3.5.1 Motor nerve-mediated vasodilation -- 2.3.5.2 Vascular adrenoreceptors -- 2.3.5.3 Sympathetic escape -- 3. Systemic control of cardiovascular response to exercise -- 3.1 Neural control mechanisms -- 3.1.1 Central command -- 3.1.2 Exercise pressor reflex -- 3.1.3 Baroreflex -- 3.2 Cardiac responses to exercise -- 3.2.1 Adrenergic and cholinergic receptors in heart -- 3.2.2 Heart rate -- 3.2.3 Stroke volume -- 3.2.4 Cardiac output -- 3.2.5 Cardiac muscle blood flow -- 3.3 Pulmonary hemodynamics in response to exercise -- 3.3.1. Pulmonary vessels, circulation, and gas exchange -- 3.3.1.1 Basic characteristics of pulmonary circulation -- 3.3.1.2 Pulmonary gas exchange -- 3.3.2. Pulmonary hemodynamic and oxygen kinetic responses during exercise -- 3.3.2.1 Pulmonary hemodynamic response to exercise -- 3.3.2.2 Lung oxygen uptake and blood gases during exercise -- 3.3.2.3 Right ventricle and exercise capability -- 3.4 Systemic hemodynamic responses to exercise -- 3.4.1 Brain blood flow during exercise -- 3.4.2 Renal blood flow during exercise -- 3.4.2.1 Regulation of renal blood flow and urine output under rest conditions -- 3.4.2.2 Regulation of renal blood flow and urine output during exercise -- 4. Cardiovascular response to exercise under pathological conditions -- 4.1 Obesity and diabetics -- 4.1.1 Impaired local blood flow in the exercising muscle of obesity -- 4.1.1.1 Microvascular rarefaction in the exercising muscle of obesity -- 4.1.1.2 Impaired local control of functional vasodilation in the exercising muscle of obesity -- 4.1.1.3 Basal arteriolar tone and vascular remodeling in the exercising muscle of obesity -- 4.1.2 Impaired systemic control of cardiovascular response to exercise -- 4.1.2.1 Exercise presser reflex -- 4.1.2.2 Baroreflex resetting -- 4.1.2.3 Central command -- 4.1.2.4 Systemic hemodynamic responses -- 4.2 Other pathologic conditions -- 4.2.1 Coronary insufficiency and heart failure -- 4.2.1.1 Coronary insufficiency -- 4.2.1.2 Heart failure -- 4.2.2 McArdle's disease -- References -- Author biography. |
Record Nr. | UNINA-9910155576003321 |
Xiang Lusha
![]() |
||
[San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Erectile dysfunction / / Rany Shamloul, Anthony J. Bella |
Autore | Shamloul Rany |
Pubbl/distr/stampa | [San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2014 |
Descrizione fisica | 1 online resource (82 p.) |
Disciplina | 616.692 |
Collana | Colloquium Series on Integrated Systems Physiology: From Molecule to Function to Disease |
Soggetto topico |
Impotence
Impotence - Treatment |
ISBN | 1-61504-653-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
1. Anatomy of the penis -- 1.1 Introduction -- 1.1.1 Skin and fascia -- 1.1.2 Tunica albigunea -- 1.1.3 Corpora cavernosa -- 1.1.4 Associated musculature -- 1.1.5 Penile vascular anatomy -- 1.1.6 Lymphatics -- 1.1.7 Innervation -- 1.2 The male urethra -- 1.3 Microscopic anatomy of the penis -- 1.3.1 Tunica albuginea -- 1.3.2 Corpora cavernosa ultrastructure, corpus spongiosum, and glans penis -- 1.3.3 Cavernous smooth muscle --
2. General pathophysiology -- 2.1 Dopamine -- 2.2 Oxytocin -- 2.3 Adrenocorticotropic hormones (ACTH) and related peptides -- 2.4 Nitric oxide (NO) -- 2.5 Serotonin -- 2.6 Opioid peptides -- 2.7 Prolactin -- 2.8 Sexual hormones -- 2.9 Control of cavernous smooth muscle function -- 2.9.1 Mechanism of smooth muscle contraction -- 2.9.2 Regulation of VSMC tone -- 2.10 Peripheral neurotransmitters -- 3. Diabetes and ED -- 3.1 Epidemiologic data -- 3.2 Pathophysiology -- 4. ED and cardiovascular disease -- 5. Drugs causing ED -- 5.1 Cardiovascular drugs and erectile function -- 5.2 Antihypertensive treatment and ED -- 5.3 Diuretics -- 5.3.1 [alpha]-adrenoceptor antagonists -- 5.3.2 Ace inhibitor -- 5.3.3 Calcium channel blockers -- 5.3.4 Lipid-lowering drugs (fibrates, statins) -- 5.4 Psychotropic medication -- 5.4.1 Antidepressants -- 5.4.2 Antipsychotics -- 5.5 Other psychotropic medications -- 5.5.1 Anti-androgens -- References -- Author biographies. |
Record Nr. | UNINA-9910698378103321 |
Shamloul Rany
![]() |
||
[San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
X & Y chromosomal variations : hormones, brain development, and neurodevelopmental performance / / Carole A. Samango-Sprouse, Andrea L. Gropman |
Autore | Samango-Sprouse Carole A. |
Pubbl/distr/stampa | [San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 |
Descrizione fisica | 1 online resource (138 pages) : color illustrations |
Disciplina | 572.87 |
Collana | Colloquium Series on The Developing Brain |
Soggetto topico |
Sex chromosomes
Sex chromosome abnormalities |
Soggetto genere / forma | Electronic books. |
ISBN | 1-61504-691-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Dedication -- Acknowledgments -- 1. Introduction -- 2. Meiosis and mitosis -- 3. Testosterone and 47, XXY: 3.1. Testosterone and XXY; 3.2. Summary -- 4. Endocrinological issues and hormonal manipulation in children and men with Klinefelter syndrome: 4.1. Introduction; 4.2. Materials and methods; 4.3. Results; 4.4. Future developments; 4.5. Conclusion; 4.6. Acknowledgments -- 5. Neurological functioning in 47, XXY: 5.1. Brain development; 5.2. Neurological examination in boys with XXY; 5.3. Cognitive profile; 5.4. Psychiatric disorders and X chromosome disorders; 5.5. Summary -- 6. Neuroimaging in XY chromosomal disorders: 6.1. Neuroimaging; 6.2. Gender differences in brain development; 6.3. 47, XXY and neuroimaging findings; 6.4. Epigenetic and genetic influences on brain development; 6.5. 47, XXX and neuroimaging findings; 6.6. Neuroimaging findings and XYY; 6.7. 49, XXXXY and neuroimaging findings; 6.8. The extra X vs. the extra Y; 6.9. Conclusions -- 7. The evolving perspective on X and Y chromosomal disorders: 7.1. Early international studies; 7.2. Growth; 7.3. Motor development; 7.4. Speech and language; 7.5. Temperament; 7.6. Conclusion -- 8. Infant development in X and Y chromosomal disorders: 8.1. Progression of neuromotor skills; 8.2. Symmetry and movement; 8.3. Timing of physical therapy; 8.4. Speech and language development; 8.5. Speech and language dysfunction: symptoms of XY chromosomal disorder; 8.6. Temperament; 8.7. Summary --
9. Phenotype and developmental progression of X and Y chromosomal variations: 9.1. 47, XXY; 9.2. ADHD; 9.3. Reading function; 9.4. Speech and language; 9.5. Biological treatment; 9.6. Behavioral issues; 9.7. 47, XYY; 9.8. 47, XXX; 9.9. Summary of developmental progression in X and Y chromosomal disorders -- 10. Social language in X and Y chromosomal variations: 10.1. Introduction; 10.2. Social language and cognition within autistic diagnoses; 10.3. 47, XXX (Triple X, Trisomy X); 10.4. 48, XXXX (Tetra X); 10.5. Social language development in variant forms of XY chromosomal disorders; 10.6. Conclusions for communication improvement in children with XY variants; 10.7. The social profile of 47, XXY; 10.8. The social profile of 47, XYY; 10.9. Conclusions for 47, XXY and 47, XYY -- 11. Conclusions -- References -- Author biographies. |
Record Nr. | UNINA-9910136208203321 |
Samango-Sprouse Carole A.
![]() |
||
[San Rafael, California] : , : Morgan & Claypool Life Sciences, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|